MSN: Researchers study how immunotherapy affects COVID-19 outcomes

MSN highlighted recent research from the University of Cincinnati Cancer Center on how immunotherapy treatments and immunosuppression affects the severity of COVID-19 infections for patients with cancer.

Trisha Wise-Draper, MD, PhD, co-led the research that was recently published in JAMA Oncology.

"We reviewed patients with cancer, those that had baseline immunosuppression, and those that were treated with immunotherapy prior to getting COVID-19," said Wise-Draper, associate professor of medicine in the Division of Hematology/Oncology, section head for Medical Oncology in UC’s College of Medicine, Head and Neck Center of Excellence co-leader and a UC Health physician. "The most important finding is that although those treated with immunotherapy alone did not have an effect on COVID-19 disease outcomes, those that had baseline immunosuppression and were treated with immunotherapy had worse outcomes with COVID-19." 

Read the MSN story.